WEDNESDAY, April 12, 2017 -- Close to half of breast cancer patients who chose to have a double mastectomy after genetic testing didn't actually have the gene mutations known to raise the risk of additional cancers, a new survey found.
"That was a bit surprising, because we wouldn't typically expect that surgery to be conducted for women if they don't have a risk-causing gene mutation," said lead researcher Dr. Allison Kurian. She is an associate professor of medicine, health research and policy at Stanford University.
MONDAY, May 1, 2017 -- Score yet another point for low-dose aspirin: Regularly taking "baby" aspirin appears to protect women from the most common type of breast cancer, new research suggests.
Use of low-dose aspirin at least three times a week was linked to a 20 percent risk reduction for cancers known as hormone-receptor positive, HER2 negative -- the most common breast cancer subtype, said study senior author Leslie Bernstein.
TUESDAY, Feb. 28, 2017 -- Thanks to high-tech imaging, mammograms ordered when breast cancer is suspected are catching more tumors -- but the percentage of false alarms is up, too, a new study finds.
These so-called diagnostic mammograms are performed because of certain symptoms or other suspicious findings. They are not the same as routine screening mammograms, said the study's lead author, Brian Sprague.